Posted Date December 2, 2021 Report Number 22-013 Related FOIA Reading Room Materials Findings of Misconduct by a then Senior Official with the Drug Enforcement Administration for Misuse of Official Position Related to Giving Preferential Treatment to a Pharmaceutical Company, and Related Misconduct Component Drug Enforcement Administration Report Type Investigation